Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00044434 · ClinicalTrials.gov registry record · Phase 4
Bupropion as a Smoking Cessation Aid in Alcoholics
A Phase 4 study, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- Completed
- Registry status
- Phase 4
- Development phase
- 200
- Enrollment target
NCT00044434 is a Phase 4 study that has completed, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA). The registered enrollment target is 200 participants.
The verdict
NCT00044434, a Phase 4 study, has completed, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to test the use of time-released bupropion (Wellbutrin) in patients receiving treatment for alcohol abuse/dependence as an aid to stop smoking. Patients will receive either a time-released bupropion or placebo. Both groups will receive nicotine replacement therapy during the 9 week study. A final followup assessment will be conducted 6 months from the start of treatment.
Interventions
- DRUG bupropion (Wellbutrin)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2002-05 |
| Est. Completion | 2005-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00044434
The ClinicalTrials.gov registry entry for NCT00044434 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which bupropion (Wellbutrin) is the first listed.
NCT00044434 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00044434 about?
NCT00044434 is a clinical study titled "Bupropion as a Smoking Cessation Aid in Alcoholics". The purpose of this study is to test the use of time-released bupropion (Wellbutrin) in patients receiving treatment for alcohol abuse/dependence as an aid to stop smoking. Patients will receive either a time-released bupropion or placebo. Both groups will receive nicotine replacement therapy during...
What is the current status of trial NCT00044434?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2002-05. Estimated completion is 2005-04.
What interventions are being tested in trial NCT00044434?
The interventions under investigation include: bupropion (Wellbutrin) (DRUG).
Who is sponsoring clinical trial NCT00044434?
This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.